The physiology, signaling, and pharmacology of dopamine receptors JM Beaulieu, RR Gainetdinov Pharmacological reviews 63 (1), 182-217, 2011 | 3235 | 2011 |
An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior JM Beaulieu, TD Sotnikova, S Marion, RJ Lefkowitz, RR Gainetdinov, ... Cell 122 (2), 261-273, 2005 | 1169 | 2005 |
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade JM Beaulieu, TD Sotnikova, WD Yao, L Kockeritz, JR Woodgett, ... Proceedings of the National Academy of Sciences 101 (14), 5099-5104, 2004 | 930 | 2004 |
Tryptophan hydroxylase-2 controls brain serotonin synthesis X Zhang, JM Beaulieu, TD Sotnikova, RR Gainetdinov, MG Caron Science 305 (5681), 217-217, 2004 | 849 | 2004 |
The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 176, S21-S141, 2019 | 754 | 2019 |
Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression X Zhang, RR Gainetdinov, JM Beaulieu, TD Sotnikova, LH Burch, ... Neuron 45 (1), 11-16, 2005 | 632 | 2005 |
Dopamine receptors–IUPHAR R eview 13 JM Beaulieu, S Espinoza, RR Gainetdinov British journal of pharmacology 172 (1), 1-23, 2015 | 630 | 2015 |
Akt/GSK3 signaling in the action of psychotropic drugs JM Beaulieu, RR Gainetdinov, MG Caron Annual review of pharmacology and toxicology 49, 327-347, 2009 | 613 | 2009 |
The Akt–GSK-3 signaling cascade in the actions of dopamine JM Beaulieu, RR Gainetdinov, MG Caron Trends in pharmacological sciences 28 (4), 166-172, 2007 | 493 | 2007 |
Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl− homeostasis F Ferrini, T Trang, TAM Mattioli, S Laffray, T Del'Guidice, LE Lorenzo, ... Nature neuroscience 16 (2), 183-192, 2013 | 463 | 2013 |
The Concise Guide to PHARMACOLOGY 2021/22: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 178, S27-S156, 2021 | 461 | 2021 |
Role of GSK3β in behavioral abnormalities induced by serotonin deficiency JM Beaulieu, X Zhang, RM Rodriguiz, TD Sotnikova, MJ Cools, ... Proceedings of the National Academy of Sciences 105 (4), 1333-1338, 2008 | 453 | 2008 |
A β-arrestin 2 signaling complex mediates lithium action on behavior JM Beaulieu, S Marion, RM Rodriguiz, IO Medvedev, TD Sotnikova, ... Cell 132 (1), 125-136, 2008 | 445 | 2008 |
Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity WD Yao, RR Gainetdinov, MI Arbuckle, TD Sotnikova, M Cyr, JM Beaulieu, ... Neuron 41 (4), 625-638, 2004 | 416 | 2004 |
Antagonism of dopamine D2 receptor/β-arrestin 2 interaction is a common property of clinically effective antipsychotics B Masri, A Salahpour, M Didriksen, V Ghisi, JM Beaulieu, RR Gainetdinov, ... Proceedings of the National Academy of Sciences 105 (36), 13656-13661, 2008 | 368 | 2008 |
Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo JM Beaulieu, E Tirotta, TD Sotnikova, B Masri, A Salahpour, ... Journal of Neuroscience 27 (4), 881-885, 2007 | 315 | 2007 |
Inhibition of GSK3 by lithium, from single molecules to signaling networks L Freland, JM Beaulieu Frontiers in molecular neuroscience 5, 14, 2012 | 307 | 2012 |
Late onset death of motor neurons in mice overexpressing wild-type peripherin JM Beaulieu, MD Nguyen, JP Julien The Journal of cell biology 147 (3), 531-544, 1999 | 290 | 1999 |
Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury M Lalancette-Hébert, V Swarup, JM Beaulieu, I Bohacek, E Abdelhamid, ... Journal of Neuroscience 32 (30), 10383-10395, 2012 | 282 | 2012 |
A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health JM Beaulieu Journal of Psychiatry and Neuroscience 37 (1), 7-16, 2012 | 277 | 2012 |